UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.     )

 

Filed by the Registrant  x

 

Filed by a Party other than the Registrant  o

 

Check the appropriate box:

o

Preliminary Proxy Statement

o

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

o

Definitive Proxy Statement

x

Definitive Additional Materials

o

Soliciting Material under §240.14a-12

 

BioTelemetry, Inc.

(Name of Registrant as Specified In Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

x

No fee required.

o

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

(1)

Title of each class of securities to which transaction applies:

 

 

 

 

(2)

Aggregate number of securities to which transaction applies:

 

 

 

 

(3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

 

 

 

(4)

Proposed maximum aggregate value of transaction:

 

 

 

 

(5)

Total fee paid:

 

 

 

o

Fee paid previously with preliminary materials.

o

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

(1)

Amount Previously Paid:

 

 

 

 

(2)

Form, Schedule or Registration Statement No.:

 

 

 

 

(3)

Filing Party:

 

 

 

 

(4)

Date Filed:

 

 

 

 


 

Important Notice of Availability of Proxy Materials for the 2017 Stockholder Meeting of

 

To Be Held On:

 

May 11, 2017 at 8:30 AM, Eastern Time,

 

at the Philadelphia Marriott West, 111 Crawford Avenue, West Conshohocken, PA 19428

 

 

 

 

 

COMPANY NUMBER

 

 

 

 

 

 

 

 

ACCOUNT NUMBER

 

 

 

 

 

 

 

 

CONTROL NUMBER

 

 

 

 

 

This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

If you want to receive a paper or e-mail copy of the proxy materials you must request one. There is no charge to you for requesting a copy. To facilitate timely delivery please make the request as instructed below before 05/01/17.

 

Please visit http://www.gobio.com in the “Investor Relations” section, where the following materials are available for view:

 

 

· Notice of Annual Meeting of Stockholders

 

· Proxy Statement

 

· Form of Electronic Proxy Card

 

· Annual Report on Form 10-K

 

 

TO REQUEST MATERIAL:

TELEPHONE: 888-Proxy-NA (888-776-9962) 718-921-8562 (for international callers)

 

 

 

E-MAIL: info@amstock.com

 

 

 

WEBSITE: https://us.astfinancial.com/proxyservices/requestmaterials.asp

 

 

 

TO VOTE:

ONLINE: To access your online proxy card, please visit www.voteproxy.com and follow the on-screen instructions or scan the QR code with your smartphone. You may enter your voting instructions at www.voteproxy.com up until 11:59 PM Eastern Time the day before the cut-off or meeting date.

 

IN PERSON: You may vote your shares in person by attending the Annual Meeting.

 

 

 

MAIL: You may request a card by following the instructions above.

 

 

 

 

 

 

 

THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE FOLLOWING PROPOSALS AND A VOTE FOR “ONE YEAR” ON PROPOSAL 3

 

 

1.

Election of the following Class I directors to hold office until the 2020 Annual Meeting.

 

 

 

 

 

 

 

 

 

Joseph H. Capper

 

 

 

 

 

 

 

 

 

Joseph A. Frick

 

 

 

 

 

 

 

 

 

Colin Hill

 

 

 

 

 

 

 

 

2.

Approval, on an advisory basis, of the compensation of our named executive officers

 

 

 

 

 

 

 

 

3.

Approval, on an advisory basis, of the frequency of holding an advisory vote on executive compensation

 

 

 

 

 

 

 

 

4.

Approval of the BioTelemetry, Inc. 2017 Omnibus Incentive Plan

 

 

 

 

 

 

 

 

5.

Approval of the BioTelemetry, Inc. 2017 Employee Stock Purchase Plan

 

 

 

 

 

 

 

 

6.

Approval of amendments to our Bylaws to change the voting requirement relating to the election of directors

 

 

 

 

 

 

 

 

7.

Approval of amendments to our Certificate of Incorporation to change the voting requirement relating to the adoption, amendment or repeal of any provision of our Bylaws

 

 

 

 

 

 

 

 

8.

Ratification of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2017.

 

 

 

 

 

 

 

 

 

 

Please note that you cannot use this notice to vote by mail.